Substrate specificity of a heparan sulfate-degrading endoglucuronidase from human placenta
- PMID: 159251
- DOI: 10.1515/bchm2.1979.360.2.1465
Substrate specificity of a heparan sulfate-degrading endoglucuronidase from human placenta
Abstract
A heparan sulfate-degrading endoglucuronidase was isolated from human placenta and partially purified by affinity chromatography on heparan sulfate-Sepharose 4B. The endoglucuronidase has a molecular weight of approximately 100 000 estimated by gel chromatography and a broad pH optimum between pH4 and pH6. Carboxyl reduced heparan sulfate is not split by partially purified endoglucuronidase, but inhibits the action of that enzyme towards non-modified heparan sulfate. Low molecular weight heparan sulfate (Mr approximately 3 000) is not attacked by the endoglucuronidase. N-Desulfated heparan sulfate and heparin are only weak substrates. The amino sugar adjacent to the glucuronic acid residue appearing at the reducing terminal of heparan sulfate fragments liberated by the endoglucuronidase appears to be exclusively N-acetylated glucosamine.
Similar articles
-
Partial purification and characterization of heparan sulfate specific endoglucuronidase.Biochem Biophys Res Commun. 1976 Dec 6;73(3):569-76. doi: 10.1016/0006-291x(76)90848-2. Biochem Biophys Res Commun. 1976. PMID: 137724 No abstract available.
-
Oligosaccharides generated by an endoglucuronidase are intermediates in the intracellular degradation of heparan sulfate proteoglycans.J Biol Chem. 1985 Jul 15;260(14):8416-22. J Biol Chem. 1985. PMID: 3159732
-
Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase.J Biol Chem. 1984 Feb 25;259(4):2283-90. J Biol Chem. 1984. PMID: 6698965
-
Multi-faceted substrate specificity of heparanase.Matrix Biol. 2013 Jun 24;32(5):223-7. doi: 10.1016/j.matbio.2013.02.006. Epub 2013 Mar 13. Matrix Biol. 2013. PMID: 23499529 Review.
-
Heparin, heparan sulfate and heparanase in cancer: remedy for metastasis?Anticancer Agents Med Chem. 2008 Jan;8(1):64-76. doi: 10.2174/187152008783330824. Anticancer Agents Med Chem. 2008. PMID: 18220506 Review.
Cited by
-
Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases.Biochem J. 1998 Nov 15;336 ( Pt 1)(Pt 1):191-200. doi: 10.1042/bj3360191. Biochem J. 1998. PMID: 9806900 Free PMC article.
-
Evidence that platelet and tumour heparanases are similar enzymes.Biochem J. 1999 Sep 1;342 ( Pt 2)(Pt 2):361-8. Biochem J. 1999. PMID: 10455023 Free PMC article.
-
A rapid quantitative assay for the detection of mammalian heparanase activity.Biochem J. 1997 Jul 1;325 ( Pt 1)(Pt 1):229-37. doi: 10.1042/bj3250229. Biochem J. 1997. PMID: 9224651 Free PMC article.
-
Heparan sulphate-degrading endoglycosidase in liver plasma membranes.Biochem J. 1988 Mar 15;250(3):719-26. doi: 10.1042/bj2500719. Biochem J. 1988. PMID: 3390139 Free PMC article.
-
Human platelet heparanase: purification, characterization and catalytic activity.Biochem J. 1998 Mar 15;330 ( Pt 3)(Pt 3):1341-50. doi: 10.1042/bj3301341. Biochem J. 1998. PMID: 9494105 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources